Stock Yards Bank & Trust Co. raised its stake in shares of Waters Co. (NYSE:WAT) by 9.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,400 shares of the medical instruments supplier’s stock after acquiring an additional 300 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Waters were worth $856,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the business. Athena Capital Advisors LLC bought a new stake in Waters in the 4th quarter valued at about $28,000. Rockland Trust Co. purchased a new position in Waters during the 4th quarter valued at about $38,000. Reilly Financial Advisors LLC grew its holdings in Waters by 334.8% during the 4th quarter. Reilly Financial Advisors LLC now owns 200 shares of the medical instruments supplier’s stock valued at $38,000 after buying an additional 154 shares in the last quarter. Lindbrook Capital LLC purchased a new position in Waters during the 4th quarter valued at about $41,000. Finally, Massey Quick Simon & CO. LLC purchased a new position in Waters during the 1st quarter valued at about $43,000. Institutional investors and hedge funds own 95.90% of the company’s stock.
A number of research firms have weighed in on WAT. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $256.00 target price for the company in a report on Wednesday, January 30th. TheStreet lowered Waters from a “b” rating to a “c+” rating in a report on Thursday, December 20th. BTIG Research lifted their target price on Waters to $260.00 and gave the company a “buy” rating in a report on Thursday, January 24th. Barclays reaffirmed a “hold” rating and set a $200.00 target price on shares of Waters in a report on Friday, January 25th. Finally, Needham & Company LLC began coverage on Waters in a report on Wednesday, January 2nd. They set a “hold” rating and a $177.00 target price for the company. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $208.99.
Shares of NYSE WAT opened at $241.99 on Thursday. Waters Co. has a 12 month low of $167.93 and a 12 month high of $255.21. The company has a quick ratio of 5.28, a current ratio of 5.93 and a debt-to-equity ratio of 0.73. The stock has a market cap of $16.99 billion, a PE ratio of 28.97, a price-to-earnings-growth ratio of 2.46 and a beta of 1.19.
Waters (NYSE:WAT) last issued its quarterly earnings data on Wednesday, January 23rd. The medical instruments supplier reported $2.87 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.64 by $0.23. Waters had a return on equity of 34.18% and a net margin of 24.54%. The company had revenue of $715.00 million during the quarter, compared to analyst estimates of $702.74 million. During the same quarter in the previous year, the firm earned $2.51 earnings per share. Waters’s revenue was up 4.0% on a year-over-year basis. Sell-side analysts anticipate that Waters Co. will post 9.35 EPS for the current year.
Waters Company Profile
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Recommended Story: Penny Stocks, What You Need To Know
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.